WAN MARK A
Insider CIK 1190472 · EPOC Director · LPDX 10% owner · CNCE 10% owner · ACRX Director, 10% owner · NVRO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TLPH TALPHERA, INC. | A Award deriv | 2026-06-22 | 2026-06-24 | 30,700 | — | $0 | 30,700 | SEC↗ |
| TLPH TALPHERA, INC. | A Award | 2026-06-22 | 2026-06-24 | 5,100 | — | $0 | 13,959 | SEC↗ |
| TLPH TALPHERA, INC. | A Award deriv | 2025-10-23 | 2025-10-24 | 25,600 | — | $0 | 25,600 | SEC↗ |
| TLPH TALPHERA, INC. | A Award | 2025-10-23 | 2025-10-24 | 4,267 | — | $0 | 8,859 | SEC↗ |
| TLPH TALPHERA, INC. | A Award deriv | 2024-06-24 | 2024-06-24 | 13,044 | — | $0 | 13,044 | SEC↗ |
| TLPH TALPHERA, INC. | A Award | 2024-06-24 | 2024-06-24 | 2,174 | — | $0 | 4,592 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2023-10-10 | 2023-12-13 | 3,487 | — | $0 | 3,487 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award | 2023-10-10 | 2023-12-13 | 581 | — | $0 | 2,418 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2022-07-15 | 2022-07-15 | 31,000 | — | $0 | 31,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award | 2022-07-15 | 2022-07-15 | 15,500 | — | $0 | 36,750 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2021-06-17 | 2021-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award | 2021-06-17 | 2021-06-17 | 10,000 | — | $0 | 21,250 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2020-06-16 | 2020-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award | 2020-06-16 | 2020-06-16 | 7,500 | — | $0 | 11,250 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2019-06-25 | 2019-06-25 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award | 2019-06-25 | 2019-06-25 | 3,750 | — | $0 | 3,750 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2018-06-14 | 2018-06-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | J Other | 2018-05-21 | 2018-05-23 | 126,153 | — | $0 | 0 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | J Other | 2018-05-21 | 2018-05-23 | 3,347,357 | — | $0 | 0 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | J Other | 2018-05-21 | 2018-05-23 | 179,962 | — | $0 | 0 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | J Other | 2018-05-21 | 2018-05-23 | 5,713,569 | — | $0 | 0 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2017-06-15 | 2017-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2016-06-21 | 2016-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2015-06-23 | 2015-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2014-11-18 | 2014-11-20 | 237,245 | $12.29 | $2.92M | 540,375 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2014-11-18 | 2014-11-20 | 12,755 | $12.29 | $156.8K | 29,052 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2014-11-18 | 2014-11-20 | 244,600 | $12.29 | $3.01M | 557,126 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2014-11-18 | 2014-11-20 | 5,400 | $12.29 | $66.4K | 12,301 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 682,475 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 1,272,187 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 204,076 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 28,090 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 15,069 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 4,506 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 1,272,187 | — | $0 | 1,276,263 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 682,475 | — | $0 | 1,958,738 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 204,076 | — | $0 | 2,162,814 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 28,090 | — | $0 | 28,180 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 4,506 | — | $0 | 47,755 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 15,069 | — | $0 | 43,249 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2014-07-24 | 2014-07-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | S Sale | 2014-03-10 | 2014-03-11 | 11,250 | $12.36 | $139.1K | 126,153 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | S Sale | 2014-03-10 | 2014-03-11 | 509,520 | $12.36 | $6.30M | 5,713,569 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | S Sale | 2014-03-10 | 2014-03-11 | 16,049 | $12.36 | $198.4K | 179,962 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | S Sale | 2014-03-10 | 2014-03-11 | 298,508 | $12.36 | $3.69M | 3,347,357 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | S Sale | 2014-03-07 | 2014-03-11 | 459 | $11.96 | $5.5K | 137,403 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | S Sale | 2014-03-07 | 2014-03-11 | 1,759 | $12.39 | $21.8K | 137,862 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | S Sale | 2014-03-07 | 2014-03-11 | 20,800 | $11.96 | $248.8K | 6,223,089 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | S Sale | 2014-03-07 | 2014-03-11 | 79,645 | $12.39 | $986.8K | 6,243,889 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | S Sale | 2014-03-07 | 2014-03-11 | 655 | $11.96 | $7.8K | 196,011 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | S Sale | 2014-03-07 | 2014-03-11 | 2,508 | $12.39 | $31.1K | 196,666 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | S Sale | 2014-03-07 | 2014-03-11 | 12,186 | $11.96 | $145.7K | 3,645,865 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | S Sale | 2014-03-07 | 2014-03-11 | 46,661 | $12.39 | $578.1K | 3,658,051 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 76,531 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 1,897,959 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 1,423,469 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 20,408 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 102,041 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 379,592 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 1,467,595 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 32,405 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 391,359 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 1,956,794 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 8,641 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 43,206 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 13,545 | — | $0 | 14,854 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2014-02-19 | 2014-02-21 | 98,219 | $14.00 | $1.38M | 777,620 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 18,060 | — | $0 | 32,914 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 251,941 | — | $0 | 276,295 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 335,922 | — | $0 | 612,217 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 67,184 | — | $0 | 679,401 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2014-02-19 | 2014-02-21 | 5,281 | $14.00 | $73.9K | 41,807 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 3,612 | — | $0 | 36,526 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 346,335 | — | $0 | 631,195 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 5,735 | — | $0 | 6,289 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2014-02-19 | 2014-02-21 | 101,264 | $14.00 | $1.42M | 801,726 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2014-02-19 | 2014-02-21 | 2,236 | $14.00 | $31.3K | 17,701 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 69,267 | — | $0 | 700,462 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 259,751 | — | $0 | 284,860 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 1,529 | — | $0 | 15,465 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 7,647 | — | $0 | 13,936 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2013-09-12 | 2013-09-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| EPOC EPOCRATES INC | D To issuer deriv | 2013-03-12 | 2013-03-13 | 15,720 | — | $0 | 0 | SEC↗ |
| EPOC EPOCRATES INC | D To issuer deriv | 2013-03-12 | 2013-03-13 | 15,720 | — | $0 | 0 | SEC↗ |
| EPOC EPOCRATES INC | D To issuer deriv | 2013-03-12 | 2013-03-13 | 11,790 | — | $0 | 0 | SEC↗ |
| EPOC EPOCRATES INC | D To issuer deriv | 2013-03-12 | 2013-03-13 | 11,790 | — | $0 | 0 | SEC↗ |
| EPOC EPOCRATES INC | D To issuer | 2013-03-12 | 2013-03-13 | 1,655,329 | — | $0 | 0 | SEC↗ |
| LPDX LIPOSCIENCE INC | C Conversion deriv | 2013-01-30 | 2013-01-31 | 25,261 | — | $0 | 0 | SEC↗ |
| LPDX LIPOSCIENCE INC | C Conversion deriv | 2013-01-30 | 2013-01-31 | 1,463,385 | — | $0 | 0 | SEC↗ |
| LPDX LIPOSCIENCE INC | C Conversion deriv | 2013-01-30 | 2013-01-31 | 878,030 | — | $0 | 0 | SEC↗ |
| LPDX LIPOSCIENCE INC | C Conversion deriv | 2013-01-30 | 2013-01-31 | 41,509 | — | $0 | 0 | SEC↗ |
| LPDX LIPOSCIENCE INC | C Conversion deriv | 2013-01-30 | 2013-01-31 | 534,339 | — | $0 | 0 | SEC↗ |
| LPDX LIPOSCIENCE INC | C Conversion deriv | 2013-01-30 | 2013-01-31 | 69,183 | — | $0 | 0 | SEC↗ |
| LPDX LIPOSCIENCE INC | C Conversion | 2013-01-30 | 2013-01-31 | 72,646 | — | $0 | 74,034 | SEC↗ |
| LPDX LIPOSCIENCE INC | P Buy | 2013-01-30 | 2013-01-31 | 205,295 | $9.00 | $1.85M | 1,771,347 | SEC↗ |
| LPDX LIPOSCIENCE INC | C Conversion | 2013-01-30 | 2013-01-31 | 1,536,688 | — | $0 | 1,566,052 | SEC↗ |
| LPDX LIPOSCIENCE INC | P Buy | 2013-01-30 | 2013-01-31 | 9,705 | $9.00 | $87.3K | 83,739 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-12-07 | 2012-12-11 | 2,364,705 | $3.31 | $7.83M | 6,323,534 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-12-07 | 2012-12-11 | 52,213 | $3.31 | $172.8K | 139,621 | SEC↗ |
| EPOC EPOCRATES INC | A Award deriv | 2012-08-13 | 2012-08-14 | 11,790 | — | $0 | 11,790 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2012-07-24 | 2012-07-26 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2012-05-29 | 2012-05-31 | 60,789 | $0.13 | $7.9K | 60,789 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2012-05-29 | 2012-05-31 | 3,268 | $0.13 | $425 | 3,268 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2012-05-29 | 2012-05-31 | 188,020 | $0.13 | $24.4K | 188,020 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2012-05-29 | 2012-05-31 | 4,151 | $0.13 | $540 | 4,151 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2012-05-29 | 2012-06-06 | 4,151 | $0.13 | $540 | 4,151 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2012-05-29 | 2012-06-06 | 60,789 | $0.13 | $7.9K | 60,789 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2012-05-29 | 2012-06-06 | 3,268 | $0.13 | $425 | 3,268 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2012-05-29 | 2012-06-06 | 188,020 | $0.13 | $24.4K | 188,020 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-05-29 | 2012-05-31 | 67,543 | $3.40 | $229.6K | 3,704,712 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-05-29 | 2012-05-31 | 4,613 | $3.40 | $15.7K | 87,408 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-05-29 | 2012-05-31 | 208,911 | $3.40 | $710.3K | 3,958,829 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-05-29 | 2012-05-31 | 3,631 | $3.40 | $12.3K | 199,174 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-05-29 | 2012-06-06 | 208,911 | $3.40 | $710.3K | 3,958,829 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-05-29 | 2012-06-06 | 67,543 | $3.40 | $229.6K | 3,704,712 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-05-29 | 2012-06-06 | 3,631 | $3.40 | $12.3K | 199,174 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-05-29 | 2012-06-06 | 4,613 | $3.40 | $15.7K | 87,408 | SEC↗ |